EMEA-002168-PIP01-17-M03

Table of contents

Key facts

Invented name
Zolgensma
Active substance
onasemnogene abeparvovec
Therapeutic area
Neurology
Decision number
P/0379/2020
PIP number
EMEA-002168-PIP01-17-M03
Pharmaceutical form(s)
Solution for injection/infusion
Condition(s) / indication(s)
Treatment of spinal muscular atrophy
Route(s) of administration
  • Intravenous use
  • Intrathecal use
Contact for public enquiries
AveXis EU Limited

E-mail: medinfo.emea@avexis.com
Tel: +353 15662364

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating
Average
2 ratings